[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Adipocyte and Cell Biology

Interferon-gamma released from omental adipose tissue of insulin-resistant humans alters adipocyte phenotype and impairs response to insulin and adiponectin release

International Journal of Obesity volume 41, pages 1782–1789 (2017)Cite this article

Subjects

Abstract

Background:

Inflammatory factors derived from adipose tissue have been implicated in mediating insulin resistance in obesity. We sought to identify these using explanted human adipose tissue exposed to innate and adaptive immune stimuli.

Methods:

Subcutaneous and omental adipose tissue from obese, insulin-resistant donors was cultured in the presence of macrophage and T-cell stimuli, and the conditioned medium tested for its ability to inhibit insulin-stimulated glucose uptake into human Simpson–Golabi–Behmel Syndrome (SGBS) adipocytes. The nature of the inhibitory factor in conditioned medium was characterized physicochemically, inferred by gene microarray analysis and confirmed by antibody neutralization.

Results:

Conditioned medium from omental adipose tissue exposed to a combination of macrophage- and T-cell stimuli inhibited insulin action and adiponectin secretion in SGBS adipocytes. This effect was associated with a pronounced change in adipocyte morphology, characterized by a decreased number of lipid droplets of increased size. The bioactivity of conditioned medium was abolished by trypsin treatment and had a molecular weight of 46 kDa by gel filtration. SGBS adipocytes exposed to a bioactive medium expressed multiple gene transcripts regulated by interferon-gamma (IFN-γ). Recombinant human IFN-γ recapitulated the effects of the bioactive medium and neutralizing antibody against IFN-γ but not other candidate factors abrogated medium bioactivity.

Conclusions:

IFN-γ released from inflamed omental adipose tissue may contribute to the metabolic abnormalities seen in human obesity.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648–1656.

    Article  CAS  Google Scholar 

  2. Zeyda M, Gollinger K, Kriehuber E, Kiefer FW, Neuhofer A, Stulnig TM . Newly identified adipose tissue macrophage populations in obesity with distinct chemokine and chemokine receptor expression. Int J Obes 2010; 34: 1684–1694.

    Article  CAS  Google Scholar 

  3. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796–1808.

    Article  CAS  Google Scholar 

  4. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821–1830.

    Article  CAS  Google Scholar 

  5. Cancello R, Tordjman J, Poitou C, Guilhem G, Bouillot JL, Hugol D et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006; 55: 1554–1561.

    Article  CAS  Google Scholar 

  6. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M et al. Insulin-sensitive obesity. Am J Physiol Endocrinol Metab 2010; 299: E506–E515.

    Article  Google Scholar 

  7. Osborn O, Olefsky JM . The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med 2012; 18: 363–374.

    Article  CAS  Google Scholar 

  8. Mathis D . Immunological goings-on in visceral adipose tissue. Cell Metab 2013; 17: 851–859.

    Article  CAS  Google Scholar 

  9. Hotamisligil GS, Shargill NS, Spiegelman BM . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993; 259: 87–91.

    Article  CAS  Google Scholar 

  10. Chavey C, Lazennec G, Lagarrigue S, Clape C, Iankova I, Teyssier J et al. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance. Cell Metab 2009; 9: 339–349.

    Article  CAS  Google Scholar 

  11. Wascher TC, Lindeman JH, Sourij H, Kooistra T, Pacini G, Roden M . Chronic TNF-alpha neutralization does not improve insulin resistance or endothelial function in 'healthy' men with metabolic syndrome. Mol Med 2011; 17: 189–193.

    Article  CAS  Google Scholar 

  12. van Asseldonk EJ, Stienstra R, Koenen TB, Joosten LA, Netea MG, Tack CJ . Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2011; 96: 2119–2126.

    Article  CAS  Google Scholar 

  13. Mestas J, Hughes CC . Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731–2738.

    Article  CAS  Google Scholar 

  14. Wabitsch M, Brenner RE, Melzner I, Braun M, Moller P, Heinze E et al. Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord 2001; 25: 8–15.

    Article  CAS  Google Scholar 

  15. Gurnell M, Wentworth JM, Agostini M, Adams M, Collingwood TN, Provenzano C et al. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis. J Biol Chem 2000; 275: 5754–5759.

    Article  CAS  Google Scholar 

  16. Deng T, Lyon CJ, Minze LJ, Lin J, Zou J, Liu JZ et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab 2013; 17: 411–422.

    Article  CAS  Google Scholar 

  17. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015; 43: e47.

    Article  Google Scholar 

  18. Silver JD, Ritchie ME, Smyth GK . Microarray background correction: maximum likelihood estimation for the normal-exponential convolution. Biostatistics 2009; 10: 352–363.

    Article  Google Scholar 

  19. Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK . Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat 2016; 10: 946–963.

    Article  Google Scholar 

  20. Shi W, Oshlack A, Smyth GK . Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips. Nucleic Acids Res 2010; 38: e204.

    Article  Google Scholar 

  21. Smyth GK, Michaud J, Scott HS . Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005; 21: 2067–2075.

    Article  CAS  Google Scholar 

  22. Wu D, Lim E, Vaillant F, Asselin-Labat ML, Visvader JE, Smyth GK . ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 2010; 26: 2176–2182.

    Article  CAS  Google Scholar 

  23. Wu D, Smyth GK . Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res 2012; 40: e133.

    Article  CAS  Google Scholar 

  24. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdottir H, Tamayo P, Mesirov JP . Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011; 27: 1739–1740.

    Article  CAS  Google Scholar 

  25. Tiller G, Laumen H, Fischer-Posovszky P, Finck A, Skurk T, Keuper M et al. LIGHT (TNFSF14) inhibits adipose differentiation without affecting adipocyte metabolism. Int J Obes 2011; 35: 208–216.

    Article  CAS  Google Scholar 

  26. Boehm U, Klamp T, Groot M, Howard JC . Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749–795.

    Article  CAS  Google Scholar 

  27. Esser N, L'Homme L, De Roover A, Kohnen L, Scheen AJ, Moutschen M et al. Obesity phenotype is related to NLRP3 inflammasome activity and immunological profile of visceral adipose tissue. Diabetologia 2013; 56: 2487–2497.

    Article  CAS  Google Scholar 

  28. Hajri T, Tao H, Wattacheril J, Marks-Shulman P, Abumrad NN . Regulation of adiponectin production by insulin: interactions with tumor necrosis factor-alpha and interleukin-6. Am J Physiol Endocrinol Metab 2011; 300: E350–E360.

    Article  CAS  Google Scholar 

  29. Stolic M, Russell A, Hutley L, Fielding G, Hay J, MacDonald G et al. Glucose uptake and insulin action in human adipose tissue–influence of BMI, anatomical depot and body fat distribution. Int J Obes Relat Metab Disord 2002; 26: 17–23.

    Article  CAS  Google Scholar 

  30. De Maeyer E, De Maeyer-Guignard J . Interferon-gamma. Curr Opin Immunol 1992; 4: 321–326.

    Article  CAS  Google Scholar 

  31. Yip YK, Pang RH, Urban C, Vilcek J . Partial purification and characterization of human gamma (immune) interferon. Proc Natl Acad Sci USA 1981; 78: 1601–1605.

    Article  CAS  Google Scholar 

  32. Baccala R, Kono DH, Theofilopoulos AN . Interferons as pathogenic effectors in autoimmunity. Immunol Rev 2005; 204: 9–26.

    Article  CAS  Google Scholar 

  33. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930–939.

    Article  CAS  Google Scholar 

  34. Wali JA, Thomas HE, Sutherland AP . Linking obesity with type 2 diabetes: the role of T-bet. Diabetes Metab Syndrome Obes 2014; 7: 331–340.

    CAS  Google Scholar 

  35. Khazen W, Distel E, Collinet M, Chaves VE, M'Bika JP, Chany C et al. Acute and selective inhibition of adipocyte glyceroneogenesis and cytosolic phosphoenolpyruvate carboxykinase by interferon gamma. Endocrinology 2007; 148: 4007–4014.

    Article  CAS  Google Scholar 

  36. McGillicuddy FC, Chiquoine EH, Hinkle CC, Kim RJ, Shah R, Roche HM et al. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J Biol Chem 2009; 284: 31936–31944.

    Article  CAS  Google Scholar 

  37. Keay S, Grossberg SE . Interferon inhibits the conversion of 3T3-L1 mouse fibroblasts into adipocytes. Proc Natl Acad Sci USA 1980; 77: 4099–4103.

    Article  CAS  Google Scholar 

  38. Wada T, Hoshino M, Kimura Y, Ojima M, Nakano T, Koya D et al. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2011; 300: E1112–E1123.

    Article  CAS  Google Scholar 

  39. Simons PJ, van den Pangaart PS, Aerts JM, Boon L . Pro-inflammatory delipidizing cytokines reduce adiponectin secretion from human adipocytes without affecting adiponectin oligomerization. J Endocrinol 2007; 192: 289–299.

    Article  CAS  Google Scholar 

  40. O'Rourke RW, White AE, Metcalf MD, Winters BR, Diggs BS, Zhu X et al. Systemic inflammation and insulin sensitivity in obese IFN-gamma knockout mice. Metabolism 2012; 61: 1152–1161.

    Article  CAS  Google Scholar 

  41. Rocha VZ, Folco EJ, Sukhova G, Shimizu K, Gotsman I, Vernon AH et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 2008; 103: 467–476.

    Article  CAS  Google Scholar 

  42. Wong N, Fam BC, Cempako GR, Steinberg GR, Walder K, Kay TW et al. Deficiency in interferon-gamma results in reduced body weight and better glucose tolerance in mice. Endocrinology 2011; 152: 3690–3699.

    Article  CAS  Google Scholar 

  43. Stolarczyk E, Vong CT, Perucha E, Jackson I, Cawthorne MA, Wargent ET et al. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab 2013; 17: 520–533.

    Article  CAS  Google Scholar 

  44. Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, Zhang C et al. Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci USA 2013; 110: 13079–13084.

    Article  CAS  Google Scholar 

  45. Faber DR, Moll FL, Vink A, van der Waal C, Kalkhoven E, Schipper HS et al. Adipose tissue quantity and composition contribute to adipokine concentrations in the subclavian vein and the inferior mesenteric vein. Int J Obes 2012; 36: 1078–1085.

    Article  CAS  Google Scholar 

  46. Glass CK, Olefsky JM . Inflammation and lipid signaling in the etiology of insulin resistance. Cell Metab 2012; 15: 635–645.

    Article  CAS  Google Scholar 

  47. Turer AT, Scherer PE . Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012; 55: 2319–2326.

    Article  CAS  Google Scholar 

  48. Faber DR, van der Graaf Y, Westerink J, Kanhai DA, Monajemi H, Visseren FL et al. Hepatocyte growth factor and interferon-gamma inducible protein-10 are related to visceral adiposity. Eur J Clin Invest 2013; 43: 369–378.

    Article  CAS  Google Scholar 

  49. Zhang X, Shen J, Man K, Chu ES, Yau TO, Sung JC et al. CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis. J Hepatol 2014; 61: 1365–1375.

    Article  CAS  Google Scholar 

  50. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914–920.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to the trial participants. This work was supported by the Australian National Health and Medical Research Council (Program Grant 1037321 and Fellowship 1080887 to LCH, Program Grant 1016647 to JGZ, Program Grant 1054618 and Fellowship 1058892 to GKS and CRE 1078106 Fellowship to JMW). This work was made possible through Victorian State Government Operational Infrastructure Support and Australian National Health and Medical Research Council Research Institute Infrastructure Support Scheme.

Author contributions

JMW takes full responsibility for the work as a whole, including the study design, access to data and the decision to submit and publish the manuscript. JMW and LCH designed the study, analyzed the data and prepared the manuscript. JMW performed most experiments, with contributions from JGZ, EB and GN. CL, MR and GS analyzed the microarray data. PEO recruited participants and obtained tissue samples. All authors edited the manuscript.

Author information

Authors and Affiliations

  1. Department of Population Health and Immunity, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

    J M Wentworth, J-G Zhang, E Bandala-Sanchez, G Naselli, R Liu, M Ritchie, G K Smyth & L C Harrison

  2. Department of Medical Biology, University of Melbourne, Parkville, VIC, Australia

    J M Wentworth, J-G Zhang, E Bandala-Sanchez, G Naselli, M Ritchie & L C Harrison

  3. Department of Medicine, University of Melbourne, Parkville, VIC, Australia

    J M Wentworth

  4. Centre for Obesity Research and Education, Monash University, Melbourne, VIC, Australia

    J M Wentworth & P E O'Brien

  5. Department of Mathematics and Statistics, University of Melbourne, Parkville, VIC, Australia

    G K Smyth

Authors
  1. J M Wentworth
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J-G Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Bandala-Sanchez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G Naselli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Ritchie
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G K Smyth
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P E O'Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. L C Harrison
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J M Wentworth.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wentworth, J., Zhang, JG., Bandala-Sanchez, E. et al. Interferon-gamma released from omental adipose tissue of insulin-resistant humans alters adipocyte phenotype and impairs response to insulin and adiponectin release. Int J Obes 41, 1782–1789 (2017). https://doi.org/10.1038/ijo.2017.180

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2017.180

Search

Advanced search

Quick links